Extensive analysis of tumors has demonstrated homozygous and heterozygous deletions in chromosome region 13q14.3 in B-cell chronic lymphocytic leukemia (B-CLL), suggesting the site of a tumor suppressor gene. Since previous searches for this gene have not yielded any viable candidates, we now present the sequence of the BACs which span the minimally deleted approximately 650 kb region between markers D13S319 and D13S25. This sequence has allowed us to create the de®nitive transcription map for the region which reveals 93 ESTs and 12 Unigene clusters in this region. Using gene prediction programs, a further 19 potential genes are also identi®ed. The genes show an asymmetrical distribution throughout the region with most of them clustering at the extreme ends. This sequencing eort provides for the de®nitive structure of the B-CLL deletion region and the identi®cation of the vast majority of the potential candidate genes. Of all the genes identi®ed, only three have homologies to known genes: two L1 repeat genes and rabbit epididymal protein 52. This 13q14.3 sequence provides the ®nal substrate from which to characterize the B-CLL tumor suppressor gene.
Introduction
Cytogenetic analysis of B-cell chronic lymphocytic leukemia identi®es two common abnormalities: those with trisomy for chromosome 12 (Pittman and Catovsky, 1983; Juliusson et al., 1988; Bienz et al., 1993; Escudier et al., 1993) and those carrying structural abnormalities involving chromosome 13 (Fitchett et al., 1987; Juliusson et al., 1988; Petersen et al., 1992) . The chromosome 13 abnormalities mainly consist of varying length deletions in the 13q14 region, but chromosome translocations with a chromosomal breakpoint in 13q14 have also been observed in 20 ± 30% of the cases (Fitchett et al., 1987) . Often these chromosome 13 abnormalities exist as the only cytogenetic change in the tumor cells (Fitchett et al., 1987) , implicating this region of chromosome 13 in the etiology of a subset of B-CLL. From an analysis of somatic cell hybrids, where the two derivatives of several reciprocal translocations were isolated in independent clones, it became clear that the chromosome 13 translocations merely served as a means of generating a submicroscopic deletion rather than generating a chimeric fusion gene (Hawthorn et al., 1993; Brown et al., 1993) . These somatic cell hybrids also served to de®ne the extent of the minimally deleted region in 13q14 (Brown et al., 1993; Hawthorn et al., 1993) . From a limited series of hybrids it could be shown that the commonly deleted region spanned approximately 1 Mbp of DNA in 13q14.3. Importantly, the retinoblastoma gene (RBI), which is also located in 13q14, was shown to lie outside the commonly deleted region (Hawthorn et al., 1993) and is therefore unlikely to be involved in the development of this leukemia.
With the de®nition of a minimally deleted region in 13q14.3 between markers D13S31 and RB1 it became possible to analyse larger numbers of tumors for loss of heterozygosity (LOH) status where it was soon shown that homozygous deletions were largely centered around the D13S25 locus (Chapman et al., 1994) . The observation of homozygous deletions also demonstrated that it is the loss of function of a critical gene in 13q14 which is important in the development of B-CLL. Subsequent analyses of larger numbers of tumors con®rmed the observation of homozygous deletions and enabled a re®nement of the limits of the minimally deleted region (Bullrich et al., 1996; Bouyge-Moreau et al., 1997) . Although there is some variation between reports attempting to de®ne ever decreasing sizes of the critical region, these often depended on the observation in single tumors which might have been due to peculiar rearrangements in these cases, possibly unrelated to leukemogenesis. At present, the critical region is approximately 700 kb and is bounded by markers D13S319 and D13S25.
The other important development in the search for a B-CLL-related gene was the preparation of increasingly detailed maps of the critical region in 13q14 (Kooy et al., 1994; Bullrich et al., 1996; Kalachikov et al., 1997; Bouyge-Moreau et al., 1997) . This mapping data ultimately resulted in the ®rst physical contig of YACs spanning the region (Hawthorn et al., 1995) which was soon followed by several other reports (Bullrich et al., 1996; Kalachikov et al., 1997; Bouyge-Moreau et al., 1997) . These YAC maps gave way to contigs of smaller clones and the addition of many new markers to the region. At this point there were still very few genes and ESTs which could be localized within these contigs. In order to increase the number of candidate genes in the regions, and not rely on the random mapping of genes, we undertook to sequence the entire region spanning the D13S319-D13S25 interval. We have now generated contiguous sequence over 570 kb of this region and have identi®ed another sequencing eort from the Sanger Center which completes the approximately 77 kb of sequence constituting a single gap in the contig. Using this genomic sequence, it has now been possible to identify all of the ESTs which map into this region as well as to de®ne genes not in the EST database using gene prediction programs. A summary of this information is presented here to facilitate the testing of candidate genes for involvement in the development of B-CLL.
Results
The consensus deletion in B-CLL lies between the D13S319 (proximal) and D13S25 (distal) markers. Although there have been suggestions that the region may be smaller and may extend more proximally, these potential re®nements have been based on results from isolated cases which may represent random events and so be misleading. The more extended region is very consistent between and within studies and we have therefore undertaken the sequencing and analysis of this entire region. The initial substrate for this sequencing eort was the BAC contig described by Hawthorn and Cowell (1998) .
Two BACs, 460F10 and 468P13, were central to this contig (Figure 1) , although the precise extent of overlap was not determined because of the limited number of markers available at the time. BAC 468P13 has been completely sequenced (AC005949) and is approximately 143 kb long. Although BAC 460F10 is still represented by two contigs (AC005948), 121 and 32 kb long, we know that the gap is relatively small and probably does not contain coding regions. We have repeatedly been unable to resolve this gap because the repeat sequences within it are refractory to sequencing. Despite this, because of the presence of individual markers from the physical map in these individual fragments, we were able to establish their relative linear order and orientation (Figure 1) . Furthermore, the size of BAC 460F10, on pulse ®eld gel electrophoresis, was maximally 155 kb and, since we have established over 155 kb of the sequence, it is clear that these gaps are relatively small. Also, since they appear to contain repetitive sequences, it is again unlikely that any signi®cant coding regions are present in the missing regions. BACs 460F10 and 468P13 overlap by approximately 92 kb, which was more than we originally anticipated, and together they represent a 202 kb contig.
Our analysis of BAC 460F10 has established the relative order and orientation of the smaller contig at the proximal end. This information then allowed us to identify the SP6 end of BAC 2252C9 from the GSS BAC-end sequence database since it overlapped with 460F10. The T7 end was not available and so we generated this sequence and demonstrated that it extended the contig proximally towards D13S319. BAC 2252C9 was also sequenced and shown to be 140, 312 bp long (AC013358). Taken together BACs 2252C9, 460F10 and 468P13 provide a 312 kb contig. To complete the contig at the proximal end we used the D13S319 marker, as well as several other more proximal markers from the physical map of the region, to isolate BAC 317G11 (Figure 1 ). This BAC was estimated to be 130 kb long and has been completely sequenced (AC069475). PCR primers from unique sequence in the T7 end of BAC 2252C9 demonstrated that BACs 317G11 and 2252C9 did not overlap. End sequencing of both of these BACs allowed us to generate PCR primers to isolate another BAC, 2302O19, which by PFGE is 110 kb long, and which spans the gap between BACs 317 and 2252 (Figure 1 ). The continuity between adjacent BACs was veri®ed by aligning sequences from each BAC clone. The T7 endsequence of 2302O19 is known (Figure 1) which allowed us to demonstrate that the overlap with 2252C9 extends over 74 kb. BAC 2302O19 has also been sequenced (AC079045). In all this represents a 450 kb contig ( Figure 1 ).
Next we analysed the more distal BAC in the contig, 168L22 (Hawthorn and Cowell, 1998) which generated 120 kb of sequence (AC007304), which is consistent with the PFGE size estimate. Marker D13S25 was identi®ed in this sequence and so the distal end of the contig is anchored in this clone. BAC 168L22 does not overlap with BAC 468P13 (Figure 1 ) as previously thought, which we now know is because the STS originally used to establish this overlap was from within a repetitive sequence present in both BACs. The availability of the sequence from these three BACs, however, allowed us to identify other BACs present in the Genomic Survey Sequence (GSS) and TIGR BAC end clone collection through BLAST searches. These BACs are not described in Figure 1 and in many cases only one of their ends had been sequenced. Of the GSS BACs, however, three, R112F3, 2199O12 and 2292J8 ( Figure 1 ) were analysed further. The T7 end clone from this BAC contained repetitive sequences but the T7 clone from 219O12 did not and could be shown to be present in 468P13. BAC 2292J8 overlapped considerably with 168L22 as shown by sequence alignment. The distal end clones from 460F10 and 468P13 were present in R-112F3 and sequence alignment showed an overlap of 51 kb. The overlap of the SP6 end of R112F3 with 168L22 was less than 5 kb. Since the R112F3 BAC is 150 kb long we estimate the gap at this end of the contig to be approximately 90 kb. Since R-112F3 was the smallest BAC spanning this region and is currently being prepared for sequencing. Together, therefore, we have completely sequenced 570 kb of the 650 kb representing the B-CLL region.
During the construction of this BAC contig, we identi®ed four other BAC clones by database searches in the high throughput genomic sequences (htgs) database using BLASTN. Thus, RP11-34f20, -480p3, -36914, -48h1 and -175b12 (Accession #AL137060, AL157367, AL138696, AL158195, and AL161424, respectively) are also localized to this region ( Figure   1 ) and their relative orientation can be established with respect to the other BACs we have characterized. These clones are still in the early stages of being sequenced by the Sanger Center as part of the genome sequencing project and are currently represented by many small contigs. Including data from RP11-175b12, however, we can clearly identify all of the missing 77 kb gaps from our contig. Thus, the information about ESTs from this gap is now available. The length of the D13S319-D13S25 interval, therefore, has now been shown to be approximately 650 kb, which is consistent with other estimates of the length of this region (Bezieau et al., 1998; Bouyge-Moreau et al., 1997) . The total sequence available has now allowed for the construction of a very detailed transcription map of the region.
Transcription map of the B-CLL deletion region
Some of the landmark loci (ESTs and STS) used to construct the physical map and de®ne the minimal region of LOH in B-CLL are shown in Figure 1 . To identify transcripts from the B-CLL region, we analysed the complete genomic genomic sequences for the presence of EST markers using the BLASTN program against the dbEST database. A summary of all of the ESTs identi®ed is shown in Figure 2 , where it can be seen that there is an uneven distribution along the length of the contig, with the majority of ESTs clustering at the very ends and relatively few in between. With the exception of AI337241, all ESTs showed more than 90% identity with the genomic sequences, suggesting that they probably originated from the 3' untranslated regions of genes. Another possibility, however, is that the dbEST carries sequences derived from genomic DNA contamination in cDNA libraries. In all, 93 ESTs were identi®ed and their relative distribution throughout the region is shown in Figure 2 . All of these putative ESTs were then compared with the unique human gene sequence collection (UniGene) database supported by NCBI (Schuler et al., 1996) . A summary of this information is given in Table 1 . No Unigene entries were found for the unique region de®ned by BACs 2302O19 and 2252C9. In contrast, eight were found within BAC 317G11, only two for the 202 kb contig for BACs 468/ 460 and a single Unigene entry was found for BAC 168L22. A single Unigene cluster was also found for the 77 kb gap represented by BAC R-175b12. In all, 12 Unigene clusters were identi®ed accounting for 31 ESTs, thereby reducing the maximum number of potential genes de®ned by ESTs in this region to 74. The details of the sizes of the clustered sequences are given in Table 1 , where it can be seen that, with two exceptions, all of them are relatively short. Only three of these clusters showed any homology with known genes (Table 1) . BACs 317G11 and R34F20 overlap considerably and we were able to determine which of the ESTs in this region were present in both (Table 1) . We could also establish which of the ESTs are present only in R34F20 and so must lie proximal to the critical deletion region. We have included data about this latter group of genes in Table 1 for completeness but they are excluded from the overall analysis.
Of note is that very few known genes are present in the deletion region. The exceptions are the LEU series Transcript map of B-CLL deletion E Kitamura et al of genes: LEU1, LEU2, and LEU5. LEU5 (Hs. 151428) which were identi®ed on one of contig sequences from RP11-34f20 (8512-56647). A database search against dbEST using the 10 kb genomic sequence including LEU5 revealed that three unigene clusters, Hs. 151428, Hs. 42321, and Hs. 5244 were localized within a 6.6 kb region from the start codon of LEU5. Importantly, however, this series of genes lies outside the critical region de®ned by D13S319-D13S25. Sequence analysis of two cDNA clones (T87218, AA595281) from Hs. 5244 combined the two Unigene clusters, Hs.5244 and Hs. 42321 into a single 3.3-kb gene. There is a possibility that these three unigene clusters could represent the 3' UTR of LEU5 since the largest LEU5 transcript is 7.5 kb (763) and the unigene clusters all mapped to a 6.6 kb region downstream of the LEU5 start codon. Sequence analysis of the other nine unigene clusters using BLASTX showed only Hs 132908 with any similarity to a known gene (SM-D1) so far.
As an alternative approach to identify expressed sequences, we subjected the 312, the 124 and 120 kb sequences to the Genome Analysis Pipeline (see Materials and methods). The program predicted 17 potential genes and 74 exons from the 312 kb sequence and nine potential genes, 30 exons, and one CpG island from 120 kb sequence ( Figure 3 , Table 2 ). The only overlap between the ESTs and predicted genes was that Grail-predicted gene #6 overlapped with EST AI337241 (Figure 3) . The same method was employed for the Genscan-predicted gene #2 from the 120 kb sequence where two (exons 4 and 8) of the eight exons predicted by Genscan overlapped with Grail-predicted exons and a CpG island was located in this region although three of them (AW303167, AW 301988, AW 302657) matched with exon 8 partially.
Out of the 26 predicted genes only three showed homologies to known genes. All three genes map to the 312 kb contig. Genscan-predicted gene #2 (Table 2) showed 67% identity over 100 amino acids of the rabbit (Oryctolagus cuniculus) Epididymal protein 52 (Accession #AF109472), and may be the human homologue of this gene. Genscan-predicted genes #5 showed high homology to the ®rst open reading frame (ORF1) of the human L1 element (Accession #U93567) that encodes for a putative p40 protein containing a leucin zipper domain, while Genscan-predicted gene #9 showed homology to the second ORF of the human L1 element encoding a putative p150 protein with reverse transcriptase and endonuclease activities.
Discussion
We have used high throughput genomic sequencing to generate extensive contiguous sequence from the critical B-CLL deletion in 13q14.3. With the development of an almost complete sequence of the approximately 650 kb region, it is now possible to create the de®nitive ®ne structure physical map of genes, even though they apparently detect transcripts on Northern blots. Currently we have identi®ed 74 ESTs, which includes both single entries in the database as well as 12 Unigene clusters. It is possible that the eventual number of genes in the region will be smaller than this, as ESTs turn out to be part of the same transcripts or do not represent genes at all. Despite the greatly increased number of genes in the region, however, the search for the critical one may still be complicated by the fact that many of these leukemias carry homozygous deletions of large parts of the region. This makes it impossible to attempt to implicate candidate genes by mutation analysis, especially in the absence of an understanding of gene function. B-CLL is a disease where lymphocytes accumulate in the blood and bone marrow and death is usually due to complications resulting from this build up of cells in critical organs. Since the life span of B cells is normally regulated by the induction of apoptosis, the 13q14 deletion presumably eliminates a gene which is critical in this apoptotic signal which allows the B cells to gain a type of immortality. The expectation, however, is that in rare cases which retain heterozygosity, mutations in the remaining allele should be present. De®nition of most of the genes in the region should facilitate these mutation studies, especially since once full-length genes have been isolated, the exon/intron structure will automatically be available for these studies.
Although our original aim was to complete the entire sequence of the 600 ± 700 kb region in order to provide a complete catalog of the genes present in the region, parallel sequencing eorts allowed us to compile the entire region without completing the one small (77 kb) gap. The combined information now available has allowed us to identify all the ESTs in the region. The purpose of this report is to present the list of genes which should be characterized further for their role in B-CLL. After compiling over 570 kb of the region it was clear that the sequencing eort at the Sanger Center was providing additional sequence information which overlapped with our eort. This redundance, however, will be important for sequence veri®cation and as a possible means of identifying single nucleotide polymorphisms in the region. We, therefore, incorporated the missing components from the contig to complete the gene survey. Of the two very small gaps in BACs B460F10 and 2302O19 respectively, the missing regions appear to contain repetitive sequences which are refractory to current sequencing protocols. We feel, however, that, based on the size of the BAC and the amount of sequence that is available, these regions are small and, by its repetitive nature, is not likely to be part of an open reading frame. Consequently we did not expend the disproportional amount of time that would be required to complete this small region. Currently the Sanger sequences are also incomplete but, since the size of the BACs approximates the length of the sequence, it is very likely that most of the sequence is available and thus we could establish unequivocally the overlaps of the contigs and predict ESTs in this region.
During our annotation of the B-CLL region we encountered a number of diculties. There are many ESTs now identi®ed from throughout the region but these are still only represented by small cDNA clones which are apparently derived from the 3'UTR of genes. Even in the Unigene clusters of ESTs, only two entries represent cDNAs which are larger than 2 kb but the majority are still smaller than 1 kb. It is also possible that some of these ESTs may represent genomic contamination in the cDNA libraries, a suggestion that is reinforced by the observation for the sgs33580 EST, which was predicted to lie within an intron of a gene by the GenScan software.
The Genome Channel gene analysis program from Oak Ridge National Laboratories was used to analyse the sequence data of the completed BACs to predict potential genes in the sequence. Although 26 genes were predicted, very few cases showed concordance between the predicted exons and known ESTs. Most of the ESTs were short, 5700 bp, and therefore are likely to be derived from 3'UTRs which are not factored into the GenScan analysis. Surprisingly, many ESTs appeared to be located in the introns of predicted genes rather than at one end or the other. There are two possible suggestions, either the gene prediction programs cannot accurately identify genes based on sequence alone, or that DNA sequences supposedly derived from genes are either from DNA contamination of are derived from intronic sequences of unprocessed mRNAs. Also, with the exception of a few cases, most of the predicted genes have fewer than three exons, which is very unusual for most functional genes. Although there are other limitations of gene prediction programs, they do provide a useful starting point for further studies, such as cloning the full-length genes using conventional techniques such as cDNA library screening and RACE PCR.
Of the 26 predicted genes, only three have homologies to known genes. The central region of Genscanpredicted gene #2, from the 312 kb contig, contains 100 amino acids that are 67% identical to the rabbit epididymal protein 52. This protein, and other seminal plasma proteins, was found to be involved in semen fertility (Killian et al., 1993; Brandon et al., 1999) . Genscan-predicted gene #2 may, therefore, represent the human homologue of the rabbit epididymal protein 52 and so is unlikely to be involved in B-CLL. The two other predicted genes seem to be part of the human L1 element. A consensus L1 element is 6.0 kb long and contains a 5'UTR with an internal promoter, two open reading frames (ORF1 and ORF2), and a 3'UTR which terminates in a poly A tail. ORF1 encodes a 40-kD nucleic acid binding protein from a single exon, while ORF2 encodes a protein with endonuclease and reverse transcriptase activities. Of the 100,000 L1 elements of the human genome, only 3000 ± 4000 are full length and even a smaller number have the ability to transpose via reverse transcription. The remainder are functionally inactive due to truncations, rearrangements and nonsense mutations (Sassaman et al., 1997) . Genscan-predicted gene #6 shares homology with the ®rst ORF of the L1 element, and Genscan-predicted gene #9 shares homology with the second ORF of the L1 element. There are several reports in the literature describing the involvement of L1 element transpositions in genetic diseases, including human breast carcinoma and colon cancer (Kazazian et al., 1988; Morse et al., 1988; Miki et al., 1992; Narita et al., 1993; Holmes et al., 1994) . It is more likely, however, Transcript map of B-CLL deletion E Kitamura et al that the L1 element predicted in the 312 kb contig is functionally inactive for several reasons. First, the full genomic length of this L1 element is more than 200 kb with more than 170 kb of genomic sequence separating ORF1 from ORF2, while there are less than 100 bp between the two ORFs in the consensus sequence. Secondly, in a consensus L1 element, ORF1 encodes a p40 protein form a single exon, whereas in our case ORF1 seem to be translated from four exons covering more than 50 kb of genomic sequence (Figure 3) . Third, ORF2 of the predicted L1 element encodes a putative 23 kD protein with only 192 amino acids, which is much smaller than the normal p150 protein and lacking the key amino acids for the endonuclease and reverse transcriptase activities. In summary, we provide the ®rst transcription map of the critical region deleted in B-CLL. Although large numbers of ESTs and predicted genes can be identi®ed few match known genes and still fewer contain open reading frames. It is likely that considerable cDNA isolation will still be required since gene prediction programs do not permit compilation of many of the genes apparently in the region. Once the genes have been identi®ed, however, their exon-intron structure will be known which will facilitate mutation studies in B-CLL.
Materials and methods

Isolation of BACs
BAC clones were obtained by screening the Research Genetics Human BAC Library Pools (Release IV) or by searching the Genome Survey Sequence (GSS) databases of the NCBI's BLAST server (Altschul et al., 1990) . Individual oligonucleotide primer pairs were used to screen the pools of DNA provided using standard PCR conditions optimized for each oligonucleotide pair. Individual BACs were purchased from Research Genetics and tested against the original primers for authenticity. BAC DNA was prepared for restriction enzyme analysis and end-sequencing, as described by Roberts et al. (1998) and end-sequencing was achieved directly from the linearized BAC using T7 and SP6 vector primers.
Large-scale sequencing
The detailed procedures for cosmid DNA isolation, random shot-gun cloning,¯uorescent-based DNA sequencing and subsequent analysis have been described previously (Pan et al., 1994; Bodenteich et al., 1993; Chissoe et al., 1995; Roe et al., 1996) (http://www.genome.ou.edu/proto.html). Brie¯y, in this present study, BAC DNA was isolated free from host genomic DNA via a cleared lysate-acetate precipitation-based protocol, randomly sheared and made blunt-ended. After kinase treatment and gel puri®cation, fragments in the 1 ± 3 kb range were ligated into SmaI-cut, bacterial alkaline phosphatase (BAP)-treated pUC18 (Pharmacia) and Escherichia coli, strain XL1BlueMRF (Stratagene), was transformed by electroporation. A random library of approximately 1200 colonies were picked from each transformation, grown in Terri®c Broth (TB) medium supplemented with 100 mg of ampicillin for 14 h at 378C with shaking at 250 r.p.m., and the sequencing templates were isolated by a cleared lysatebased protocol (Bodenteich et al., 1993; Roe et al., 1996) .
Sequencing reactions were performed as previously described (Chissoe et al., 1995) using Thermus aquaticus (Taq) DNA polymerase, the Perkin-Elmer Cetus Fluorescentlabeled Big Dye Taq terminators. The reactions were incubated for 60 cycles in a Perkin-Elmer Cetus DNA Thermocycler 9600 and after removal of unincorporated dye terminators by ®ltration through Sephadex G-50, thē uorescent-labeled nested fragment sets were resolved by electrophoresis on an ABI 3700 Capillary DNA Sequencer. After base calling with the ABI Analysis Software, the analysed data was transferred to a Sun Workstation Cluster, and assembled using Phil Green's Phred and Phrap programs Overlapping sequences and contigs were analysed using the graphical tools developed by Gordon et al. (1998) . Gap closure and proofreading was performed using either custom primer walking or using PCR ampli®cation of the region corresponding to the gap in the sequence followed by sub-cloning into pUC18 and cycle sequencing with the universal pUCprimers via Taq terminator chemistry. In some instances, additional synthetic custom primers were necessary to obtain at least threefold coverage for each base.
Following manual proof-reading by viewing the data with Consed, the sequence was analysed on either a Sun workstation or Dec VAX computer with the programs contained within the GCG package (Genetics Computer Group, 1994) as well as the BLAST (Altschul et al., 1990) , BEAUTY (Worley et al., 1995) and BLOCKS (Heniko and Heniko, 1994) programs.
Computational sequence analysis
Genomic sequences were analysed in blocks of 20 kb of sequence using the BLASTN program against the dbEST database (Altschul et al., 1990) . Alignments of predicted genes against various databases were made using the Genome Analysis Pipeline (Oak Ridge National Laboratory: http:// www.ornl/GP), which predicts both genes and exons using GRAIL (Xu et al., 1994) and GENSCAN (Burge and Karlin, 1997) , as well as providing integrated GRAIL annotated features and BLAST and BEAUTY analysis.
